These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15563315)

  • 1. Lymphangiogenic growth factors as markers of tumor metastasis.
    Stacker SA; Williams RA; Achen MG
    APMIS; 2004; 112(7-8):539-49. PubMed ID: 15563315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphangiogenesis and tumor progression].
    Vittet D; Feige JJ
    Bull Cancer; 2007 Oct; 94(10):881-6. PubMed ID: 17964982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
    Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
    Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
    Tobler NE; Detmar M
    J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis and tumor metastasis: myth or reality?
    Pepper MS
    Clin Cancer Res; 2001 Mar; 7(3):462-8. PubMed ID: 11297234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma.
    Bierer S; Herrmann E; Köpke T; Neumann J; Eltze E; Hertle L; Wülfing C
    Oncol Rep; 2008 Oct; 20(4):721-5. PubMed ID: 18813809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphangiogenesis in human gynaecological cancers.
    Van Trappen PO; Pepper MS
    Angiogenesis; 2005; 8(2):137-45. PubMed ID: 16211357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
    Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
    Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways targeting tumor lymphangiogenesis.
    Wissmann C; Detmar M
    Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vascular endothelial growth factor-C and -D mRNA in breast cancer.
    Teramoto S; Arihiro K; Koseki M; Kataoka T; Asahara T; Ohdan H
    Hiroshima J Med Sci; 2008 Jun; 57(2):73-8. PubMed ID: 18717190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of vascular endothelial growth factors.
    Tammela T; Enholm B; Alitalo K; Paavonen K
    Cardiovasc Res; 2005 Feb; 65(3):550-63. PubMed ID: 15664381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.
    van der Schaft DW; Pauwels P; Hulsmans S; Zimmermann M; van de Poll-Franse LV; Griffioen AW
    Cancer Lett; 2007 Aug; 254(1):128-36. PubMed ID: 17442484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
    Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
    J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.